Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D AMSTERDAM

Showing results (41-50 of 265) with videos related to

Pageof 27
Sort By:
Journal of Psychopharmacology (Oxford, England)|February 1, 2012
Treatment-resistant depression: additional perspectivesM H Rosenzweig, J D Amsterdam
Journal of Clinical Psychopharmacology|November 6, 2019
Relative Effectiveness of Monoamine Oxidase Inhibitor and Tricyclic Antidepressant Combination Therapy for Treatment-Resistant DepressionJay D Amsterdam, Thomas T Kim
The International Journal of Risk & Safety in Medicine|November 9, 2012
The paroxetine 352 bipolar trial: A study in medical ghostwritingJay D Amsterdam, Leemon B McHenry
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|March 26, 2016
Rhodiola rosea L. as a putative botanical antidepressantJay D Amsterdam, Alexander G Panossian
Pharmacopsychiatry|January 1, 1989
High dose tranylcypromine therapy for refractory depressionJ D Amsterdam, N J Berwish
The Psychiatric Clinics of North America|June 1, 1996
Treatment algorithms in treatment-resistant depressionJ D Amsterdam, M Hornig-Rohan
Biological Psychiatry|September 15, 1993
Serum antibodies to herpes simplex virus types I and II in depressed patientsJ D Amsterdam, W J Hernz
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 9, 2002
Site variability in treatment outcome in antidepressant trialsJay D Amsterdam, David J Brunswick
The American Journal of Psychiatry|November 2, 2002
Transdermal selegiline in major depression: a double-blind, placebo-controlled, parallel-group study in outpatientsJ Alexander Bodkin, Jay D Amsterdam
Clinical Obstetrics and Gynecology|August 25, 2004
Mood disorders in women from adolescence to late life: an overviewRhonda C Boyd, Jay D Amsterdam
Pageof 27

Showing results (41-50 of 265) with videos related to

Sort By:
Pageof 27
Journal of Psychopharmacology (Oxford, England)|February 1, 2012
Treatment-resistant depression: additional perspectivesM H Rosenzweig, J D Amsterdam
Journal of Clinical Psychopharmacology|November 6, 2019
Relative Effectiveness of Monoamine Oxidase Inhibitor and Tricyclic Antidepressant Combination Therapy for Treatment-Resistant DepressionJay D Amsterdam, Thomas T Kim
The International Journal of Risk & Safety in Medicine|November 9, 2012
The paroxetine 352 bipolar trial: A study in medical ghostwritingJay D Amsterdam, Leemon B McHenry
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|March 26, 2016
Rhodiola rosea L. as a putative botanical antidepressantJay D Amsterdam, Alexander G Panossian
Pharmacopsychiatry|January 1, 1989
High dose tranylcypromine therapy for refractory depressionJ D Amsterdam, N J Berwish
The Psychiatric Clinics of North America|June 1, 1996
Treatment algorithms in treatment-resistant depressionJ D Amsterdam, M Hornig-Rohan
Biological Psychiatry|September 15, 1993
Serum antibodies to herpes simplex virus types I and II in depressed patientsJ D Amsterdam, W J Hernz
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 9, 2002
Site variability in treatment outcome in antidepressant trialsJay D Amsterdam, David J Brunswick
The American Journal of Psychiatry|November 2, 2002
Transdermal selegiline in major depression: a double-blind, placebo-controlled, parallel-group study in outpatientsJ Alexander Bodkin, Jay D Amsterdam
Clinical Obstetrics and Gynecology|August 25, 2004
Mood disorders in women from adolescence to late life: an overviewRhonda C Boyd, Jay D Amsterdam
Pageof 27